Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Saddler

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Transplantation|December 11, 2023
Incidence and outcomes of fever of unknown origin after kidney transplant in the modern eraMargaret R Jorgenson, Sandesh Parajuli, Hanna L Kleiboeker, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 21, 2019
Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomesMargaret R Jorgenson, Jillian L Descourouez, Brianna Cardinale, et al.
Clinical Transplantation|March 26, 2023
Discordance in cytomegalovirus viremia in kidney recipients from the same donor is associated with the worst outcomesEmily Zona, Margaret Jorgenson, Sonam Dolma, et al.
Clinical Transplantation|November 10, 2022
Seasonal variation of cytomegalovirus disease in kidney transplant recipientsMargaret R Jorgenson, Hanna L Kleiboeker, Brad C Astor, et al.
Clinical Transplantation|July 15, 2021
A pilot study of an intensified ganciclovir dosing strategy for treatment of cytomegalovirus disease in kidney and/or pancreas transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
The Annals of Pharmacotherapy|August 29, 2017
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant PatientsLindsey E Splinter, Luiza Kerstenetzky, Margaret R Jorgenson, et al.
Clinical Transplantation|September 4, 2024
Cytomegalovirus Post-Prophylaxis Surveillance in High-Risk Kidney and Liver Recipients Prevents CMV End-Organ Disease and Ganciclovir-ResistanceMargaret R Jorgenson, Ethan Meyer, Glen E Leverson, et al.
The Annals of Pharmacotherapy|April 23, 2019
Epidemiology, Risk Factors, and Outcomes After Early Posttransplant <i>Clostridiodes difficile</i> Infection in Renal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Dou-Yan Yang, et al.
The Annals of Pharmacotherapy|August 25, 2022
Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical ConsiderationsHanna L Kleiboeker, Jillian L Descourouez, Lucas T Schulz, et al.
Infection Control and Hospital Epidemiology|May 28, 2020
The development and implementation of stewardship initiatives to optimize the prevention and treatment of cytomegalovirus infection in solid-organ transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Lucas T Schulz, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Transplantation|December 11, 2023
Incidence and outcomes of fever of unknown origin after kidney transplant in the modern eraMargaret R Jorgenson, Sandesh Parajuli, Hanna L Kleiboeker, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 21, 2019
Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomesMargaret R Jorgenson, Jillian L Descourouez, Brianna Cardinale, et al.
Clinical Transplantation|March 26, 2023
Discordance in cytomegalovirus viremia in kidney recipients from the same donor is associated with the worst outcomesEmily Zona, Margaret Jorgenson, Sonam Dolma, et al.
Clinical Transplantation|November 10, 2022
Seasonal variation of cytomegalovirus disease in kidney transplant recipientsMargaret R Jorgenson, Hanna L Kleiboeker, Brad C Astor, et al.
Clinical Transplantation|July 15, 2021
A pilot study of an intensified ganciclovir dosing strategy for treatment of cytomegalovirus disease in kidney and/or pancreas transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Glen E Leverson, et al.
The Annals of Pharmacotherapy|August 29, 2017
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant PatientsLindsey E Splinter, Luiza Kerstenetzky, Margaret R Jorgenson, et al.
Clinical Transplantation|September 4, 2024
Cytomegalovirus Post-Prophylaxis Surveillance in High-Risk Kidney and Liver Recipients Prevents CMV End-Organ Disease and Ganciclovir-ResistanceMargaret R Jorgenson, Ethan Meyer, Glen E Leverson, et al.
The Annals of Pharmacotherapy|April 23, 2019
Epidemiology, Risk Factors, and Outcomes After Early Posttransplant <i>Clostridiodes difficile</i> Infection in Renal Transplant RecipientsMargaret R Jorgenson, Jillian L Descourouez, Dou-Yan Yang, et al.
The Annals of Pharmacotherapy|August 25, 2022
Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical ConsiderationsHanna L Kleiboeker, Jillian L Descourouez, Lucas T Schulz, et al.
Infection Control and Hospital Epidemiology|May 28, 2020
The development and implementation of stewardship initiatives to optimize the prevention and treatment of cytomegalovirus infection in solid-organ transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Lucas T Schulz, et al.
Pageof 6